Estimating the prevalence of AATD patients potentially eligible for augmentation therapy in the UK on the basis of symptomatic COPD - Open for dissemination costs only

Short title	Estimating the prevalence of AATD patients potentially eligible for augmentation therapy in the UK on the basis of symptomatic COPD - Open for dissemination costs only
Status	Finished
Effective start/end date	1/08/19 → 30/06/22

Estimating the prevalence of AATD patients potentially eligible for augmentation therapy in the UK on the basis of symptomatic COPD - *Open for dissemination costs only*